What is the address of MEDISEIV, société de médecine générale?

The registered office of MEDISEIV, société de médecine générale is located at Avenue Bouvier,St-Mard 104, 6762 Virton.

Is MEDISEIV, société de médecine générale still active?

Yes. According to the CBE (31 October 2026) MEDISEIV, société de médecine générale is active, legal situation “Normale toestand”, started on 27 January 2003.

Is MEDISEIV, société de médecine générale registered on Peppol?

No, MEDISEIV, société de médecine générale is currently not registered on the Peppol network.

What is the enterprise number of MEDISEIV, société de médecine générale?

The enterprise number of MEDISEIV, société de médecine générale is BE0479395873.

When was MEDISEIV, société de médecine générale founded?

MEDISEIV, société de médecine générale was founded on 27 January 2003.

Is MEDISEIV, société de médecine générale a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 January 2003; 5 annual accounts filed, latest fiscal year 2025.

How much profit did MEDISEIV, société de médecine générale make in 2025?

MEDISEIV, société de médecine générale posted a profit after taxes of € 98,039 in financial year 2025.

What is the revenue of MEDISEIV, société de médecine générale?

As a small company, MEDISEIV, société de médecine générale is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 149,116.

MEDISEIV, société de médecine générale (Private Limited)

Dossier MEDISEIV, société de médecine générale, printed on 1 November 2026 from databakkes.be/en/0479395873/mediseiv-societe-de-medecine-generale. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2023, 2024.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

MEDISEIV, société de médecine générale from Virton, company number BE0479395873, closed financial year 2025 with a result of € 98,039 after tax. For that financial year MEDISEIV, société de médecine générale recorded a gross margin of € 149,116 and equity of € 498,790. Compared with financial year 2024, the result moved from € 81,923 to € 98,039. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 7, 2026.

What it is worth Growing

€ 498,790

▲ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 98,039

▲ 20% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 477,107

▼ 2% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 73,000 paid out

74 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 148,690 Gross margin 2022: € 148,690 First fiscal year in the series	€ 151,260 Gross margin 2023: € 151,260 ▲ 2% vs 2022 (€ 148,690) Favourable step	€ 146,726 Gross margin 2024: € 146,726 ▼ 3% vs 2023 (€ 151,260) Unfavourable step	€ 149,116 Gross margin 2025: € 149,116 ▲ 2% vs 2024 (€ 146,726) Favourable step	▲ 2%
Profit after taxes	€ 5,842 Profit after taxes 2022: € 5,842 First fiscal year in the series	€ 95,974 Profit after taxes 2023: € 95,974 ▲ € 90,132 vs 2022 (€ 5,842) Favourable step	€ 81,923 Profit after taxes 2024: € 81,923 ▼ 15% vs 2023 (€ 95,974) Unfavourable step	€ 98,039 Profit after taxes 2025: € 98,039 ▲ 20% vs 2024 (€ 81,923) Favourable step	▲ 20%
Equity	€ 444,854 Equity 2022: € 444,854 First fiscal year in the series	€ 476,828 Equity 2023: € 476,828 ▲ 7% vs 2022 (€ 444,854) Favourable step	€ 473,751 Equity 2024: € 473,751 ▼ 1% vs 2023 (€ 476,828) Unfavourable step	€ 498,790 Equity 2025: € 498,790 ▲ 5% vs 2024 (€ 473,751) Favourable step	▲ 5%
Total debts	€ 89,031 Total debts 2022: € 89,031 First fiscal year in the series	€ 150,608 Total debts 2023: € 150,608 ▲ 69% vs 2022 (€ 89,031) Unfavourable step	€ 114,972 Total debts 2024: € 114,972 ▼ 24% vs 2023 (€ 150,608) Favourable step	€ 75,664 Total debts 2025: € 75,664 ▼ 34% vs 2024 (€ 114,972) Favourable step	▼ 34%
Cash	€ 416,569 Cash 2022: € 416,569 First fiscal year in the series	€ 518,325 Cash 2023: € 518,325 ▲ 24% vs 2022 (€ 416,569) Favourable step	€ 486,536 Cash 2024: € 486,536 ▼ 6% vs 2023 (€ 518,325) Unfavourable step	€ 477,107 Cash 2025: € 477,107 ▼ 2% vs 2024 (€ 486,536) Unfavourable step	▼ 2%
Land & buildings	€ 107,243 Land & buildings 2022: € 107,243 First fiscal year in the series	€ 103,466 Land & buildings 2023: € 103,466 ▼ 4% vs 2022 (€ 107,243) Unchanged	€ 100,841 Land & buildings 2024: € 100,841 ▼ 3% vs 2023 (€ 103,466) Unchanged	€ 97,347 Land & buildings 2025: € 97,347 ▼ 3% vs 2024 (€ 100,841) Unchanged	▼ 3%
Retained profit	€ 426,254 Retained profit 2022: € 426,254 First fiscal year in the series	€ 458,228 Retained profit 2023: € 458,228 ▲ 8% vs 2022 (€ 426,254) Favourable step	€ 455,151 Retained profit 2024: € 455,151 ▼ 1% vs 2023 (€ 458,228) Unfavourable step	€ 480,190 Retained profit 2025: € 480,190 ▲ 6% vs 2024 (€ 455,151) Favourable step	▲ 6%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 85,000 Dividend 2024: € 85,000 Unchanged (€ 0) Unchanged	€ 73,000 Dividend 2025: € 73,000 ▼ 14% vs 2024 (€ 85,000) Unchanged	▼ 14%
Balance sheet total	€ 533,885 Balance sheet total 2022: € 533,885 First fiscal year in the series	€ 627,436 Balance sheet total 2023: € 627,436 ▲ 18% vs 2022 (€ 533,885) Unchanged	€ 588,723 Balance sheet total 2024: € 588,723 ▼ 6% vs 2023 (€ 627,436) Unchanged	€ 574,454 Balance sheet total 2025: € 574,454 ▼ 2% vs 2024 (€ 588,723) Unchanged	▼ 2%

Key figures of MEDISEIV, société de médecine générale, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDISEIV, société de médecine générale?

What happened at MEDISEIV, société de médecine générale in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 7, 2026 New annual accounts for financial year 2025: profit of € 98,039 (▲ 20% vs 2024). filed late Source: NBB ↗
Jan 27, 2003 Start of the company according to the CBE. KBO

In short

From € 5,842 profit in 2022 to € 98,039 profit in 2025.

Paid € 284,987 in corporate taxes since 2022.

Best year ever: 2025, with € 98,039 profit.

Paid out € 158,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue Bouvier,St-Mard 104

6762 Virton

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0479.395.873
VAT number: BE 0479.395.873
Registered office: Avenue Bouvier,St-Mard 104, 6762 Virton
Names & denominations: MEDISEIV, société de médecine générale · MEDISEIV
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 January 2003
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDISEIV, société de médecine générale